Joseph Saddik | Pharmacology, Toxicology and Pharmaceutical Science | Best Innovation Award

Best Innovation Award

Joseph Saddik
Pfizer,United States

Joseph Saddik
Affiliation Pfizer
Country United States
Scopus ID 57223125865
Documents 2
Citations 25
h-index 2
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Excellence Awards
ORCID 0000-0003-1490-9517

Joseph Saddik is identified with research in pharmaceutical science, particularly powder rheology, tablet compaction, compactability, and manufacturing-related performance of acetaminophen tablets. His listed publications address formulation and processing variables associated with tablet manufacture and the prediction or mitigation of sticking during compression. [1][2]

Abstract

The research record associated with Joseph Saddik centers on pharmaceutical powder processing and tablet manufacturing. The documented work examines powder rheology, tablet compactability, and sticking behavior, with particular attention to formulation factors, glidant selection, punch-metal effects, and multivariate analytical approaches. These topics are relevant to pharmaceutical manufacturing because powder flow and compaction characteristics can influence tablet quality and process performance. [2][3]

Keywords

Pharmaceutical science; powder rheology; tablet compression; acetaminophen; compactability; sticking; glidants; punch metals; multivariate analysis.

Introduction

Tablet manufacture involves interconnected material and process variables. Acetaminophen is frequently used as a model active pharmaceutical ingredient for studying compression behavior because formulation and processing conditions can affect compaction and manufacturing outcomes. Research examining these relationships can support improved understanding of tablet formation and compression-related defects. [2]

Research Profile

The supplied researcher record lists Pfizer as the institutional affiliation and identifies Pharmacology, Toxicology and Pharmaceutical Science as the subject area. The supplied bibliographic information records two documents, 25 citations, and an h-index of 2, alongside Scopus author identifier 57223125865. These metrics are bibliographic indicators and should be interpreted in relation to database coverage and publication history. [1]

Research Contributions

The documented studies contribute to the characterization of pharmaceutical powders and compressed tablets. One study evaluates powder rheology as a potential predictor of tablet sticking, while another investigates manufacturing and formulation factors affecting acetaminophen compactability. The 2026 study further develops this research direction by examining glidant type and punch-metal selection in high-drug-load acetaminophen tablets. [2][3][4]

Publications

  • Predicting and Mitigating Sticking in High-Drug-Load Acetaminophen Tablets Using a Powder Rheology-Compression Approach: Evaluation of Glidant Type and Punch Metal Selection. Powders, 2026. [4]
  • Investigating the Impact of Manufacturing and Formulation Factors on the Compactability of Acetaminophen Tablets Using Heckel and Multivariate Analysis. International Journal of Pharmaceutical Sciences and Research, 2021. [2]
  • Evaluation of powder rheology as a potential tool to predict tablet sticking. Powder Technology, 2021. [3]

Research Impact

The reported citation count indicates that the research has received citations within the indexed scholarly literature. Its thematic focus also connects fundamental powder characterization with practical tablet-manufacturing concerns, including sticking and compactability. Such work may be relevant to formulation development and process understanding, although citation metrics alone do not establish practical or clinical impact. [1]

Award Suitability

For consideration in the International Academic Excellence Awards, the documented publication record provides identifiable evidence of research activity in pharmaceutical manufacturing and powder science. The studies present a coherent research theme spanning rheological characterization, compaction analysis, and mitigation of tablet sticking. Award decisions, however, remain subject to the criteria, documentation, and assessment procedures established by the awarding organization. [5]

Conclusion

Joseph Saddik’s documented research is focused on technically specific problems in pharmaceutical tablet manufacture, particularly powder rheology, compactability, and sticking. The available publications demonstrate continuity across these subjects and provide a scholarly basis for describing his research profile within pharmaceutical science. [2][3][4]

References

  1. Elsevier. (n.d.). Scopus author details: Joseph Saddik, Author ID 57223125865. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57223125865
  2. International Journal of Pharmaceutical Sciences and Research. (2021). Investigating the Impact of Manufacturing and Formulation Factors on the Compactability of Acetaminophen Tablets Using Heckel and Multivariate Analysis. DOI: 10.13040/ijpsr.0975-8232.12(2).1240-50
  3. Powder Technology. (2021). Evaluation of powder rheology as a potential tool to predict tablet sticking. DOI: 10.1016/j.powtec.2021.03.062
  4. MDPI. (2026). Predicting and Mitigating Sticking in High-Drug-Load Acetaminophen Tablets Using a Powder Rheology-Compression Approach: Evaluation of Glidant Type and Punch Metal Selection. Powders, 5(3), 31.
    https://doi.org/10.3390/powders5030031
  5. International Academic Excellence Awards. (n.d.). Award program information.
    https://academicexcellenceawards.com/
  6. ORCID. (n.d.). Joseph Saddik, ORCID record 0000-0003-1490-9517.
    https://orcid.org/0000-0003-1490-9517

Dimple Modi | Toxicology | Best Researcher Award

Dimple Modi | Toxicology | Best Researcher Award

Investigator/Principal Scientist at GlaxoSmithKline, United States 🎓

Dimple Modi is an accomplished scientific leader with over 12 years of experience in pharmaceutical research and formulation development. Specializing in dermatology/topical and parenteral applications, Modi has a proven track record in leading cross-functional teams, optimizing drug formulations, and advancing projects from conceptualization to late-stage development. With expertise in regulatory compliance, project management, and innovative drug delivery systems, Modi is known for fostering innovation and driving successful drug development initiatives.

Professional Profile 

🎓Education🧑‍🎓

Dimple Modi earned a PhD in Pharmaceutical Science from Saint Joseph’s University (formerly University of the Sciences) in Philadelphia, PA, where their research focused on enhancing the oil solubility of BCS Class II drugs and increasing drug loading in nanoemulsions. Modi also holds a Master of Science in Pharmaceutical Manufacturing Practices from Stevens Institute of Technology in Hoboken, NJ, and a Bachelor of Science in Pharmacy from L.M. College of Pharmacy in Ahmedabad, Gujarat, India.

💼Work Experience

Dimple Modi, in their role as Investigator, Drug Product Development at GlaxoSmithKline, has excelled in leading the development and optimization of long-acting injectable suspensions and parenteral solutions. Modi oversees clinical formulation strategies and project management from early to late phases, while pioneering innovative extemporaneous compounding methods. Previously, as a Senior Research Scientist at GlaxoSmithKline, Modi conducted pivotal pre-formulation studies and developed platform cream formulations using DOE methodologies. At Lupin Pharmaceuticals, Modi advanced dermatological semisolid dosage forms, managed technology transfers, and authored critical regulatory documentation. Their analytical expertise and adherence to cGMP and cGLP guidelines were honed during their tenure as an Analytical Scientist.

🔍Research Focus 

Dimple Modi’s research focuses on the development and optimization of drug formulations, particularly in dermatology and parenteral applications. Key areas include enhancing drug solubility, optimizing delivery systems, and advancing formulation strategies from lab-scale to pilot-scale manufacturing. Modi is known for innovative approaches in drug development and regulatory compliance.

🏆Awards and Honors

  • Exceptional Science Award (2018): Recognized for designing and developing a platform cream formulation that accelerated development timelines for dermatology products.
  • Multiple Bronze/Silver Awards: Received within GlaxoSmithKline for scientific accomplishments.
  • Successfully Achieved 14 ANDA Submissions and Approvals: Demonstrates significant contributions to regulatory achievements.
  • Leadership in Career Development: Actively involved in initiatives to enhance diversity and mentorship within the industry.

Conclusion

Dimple Modi’s impressive track record in pharmaceutical research, combined with leadership skills and recognized innovations, makes them a strong candidate for the “Best Researcher Award.” Their ability to drive forward complex projects, mentor future scientists, and contribute to significant advancements in drug development aligns well with the criteria for such an award. Enhancing visibility through publications and broader impact initiatives could further solidify their suitability for the award.

📖Publications : 

  1. Long acting injectables for the treatment of prostate cancer
    Modi, D., Hussain, M.S., Ainampudi, S., Prajapati, B.G.
    Journal of Drug Delivery Science and Technology, 2024, 100, 105996
  2. In situ evaluation of the impact of metformin or verapamil coadministration with vildagliptin on its regional absorption from the rabbit’s intestine
    Elmeniar, A.M., Osman, M.A., El-Gizawy, S.A., Haggag, Y.A., Tambuwala, M.M.
    Biopharmaceutics and Drug Disposition, 2024, 45(2), pp. 71–82
  3. Enhancing Oil Solubility of BCS Class II Drug Phenytoin Through Hydrophobic Ion Pairing to Enable High Drug Load in Injectable Nanoemulsion to Prevent Precipitation at Physiological pH With a Potential to Prevent Phlebitis
    Modi, D., Jonnalagadda, S., Campbell, G.A., Dalwadi, G.
    Journal of Pharmaceutical Sciences, 2023, 112(9), pp. 2427–2443
  4. Accelerate development of topical cream drug product using a common platform base formulation
    Modi, D., Sharma, H., Campbell, G.
    Pharmaceutical Development and Technology, 2020, 25(6), pp. 767–778
  5. Understanding the role of sodium lauryl sulfate on the biorelevant solubility of a combination of poorly water-soluble drugs using high throughput experimentation and mechanistic absorption modeling
    Bahr, M.N., Modi, D., Patel, S., Campbell, G., Stockdale, G.
    Journal of Pharmacy and Pharmaceutical Sciences, 2019, 22(1), pp. 221–246